PA
RGNX icon

Perceptive Advisors’s Regenxbio RGNX Stock Holding History

Perceptive Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-342,408
Closed -$6.15M – 122
2023
Q4 		$6.15M Buy
+342,408
New +$6.03M 0.14% 71
2021
Q4 		– Sell
-89,283
Closed -$3.74M – 156
2021
Q3 		$3.74M Hold
89,283
– – 0.05% 124
2021
Q2 		$3.47M Buy
89,283
+20,000
+29% +$715K 0.05% 131
2021
Q1 		$2.36M Buy
+69,283
New +$2.95M 0.03% 124
2020
Q2 		– Sell
-508,000
Closed -$17.1M – 134
2020
Q1 		$17.1M Sell
508,000
-100,000
-16% -$4.17M 0.45% 44
2019
Q4 		$24.9M Hold
608,000
– – 0.49% 45
2019
Q3 		$21.6M Sell
608,000
-362,997
-37% -$14.7M 0.58% 42
2019
Q2 		$49.9M Sell
970,997
-174,729
-15% -$8.72M 1.14% 22
2019
Q1 		$65.7M Buy
1,145,726
+500,000
+77% +$24.8M 1.85% 14
2018
Q4 		$26.9M Buy
645,726
+175,054
+37% +$10.3M 1.02% 28
2018
Q3 		$35.5M Sell
470,672
-396,434
-46% -$28.6M 0.95% 33
2018
Q2 		$62.2M Sell
867,106
-14,000
-2% -$669K 1.63% 14
2018
Q1 		$26.3M Sell
881,106
-540,080
-38% -$15.7M 0.74% 33
2017
Q4 		$47.3M Sell
1,421,186
-20,000
-1% -$603K 1.57% 16
2017
Q3 		$47.5M Buy
1,441,186
+70,000
+5% +$1.58M 1.81% 13
2017
Q2 		$27.1M Sell
1,371,186
-25,058
-2% -$485K 1.36% 21
2017
Q1 		$26.9M Buy
1,396,244
+113,958
+9% +$2.2M 1.54% 18
2016
Q4 		$23.8M Hold
1,282,286
– – 1.69% 14
2016
Q3 		$18M Buy
1,282,286
+183,073
+17% +$2.02M 1.16% 19
2016
Q2 		$8.79M Buy
1,099,213
+273,817
+33% +$3.04M 0.61% 40
2016
Q1 		$8.91M Buy
825,396
+46,183
+6% +$591K 0.78% 35
2015
Q4 		$12.9M Hold
779,213
– – 0.96% 28
2015
Q3 		$17.2M Buy
+779,213
New +$19.9M 1.37% 17

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Perceptive Advisors's RGNX Position: Q1 2024 in Review

Perceptive Advisors sold out of Regenxbio (RGNX) in Q1 2024, closing a stake of 342,408 shares — an estimated $6.15M sold.

Perceptive Advisors first reported a position in RGNX in Q3 2015 and held it in 23 quarters. The position peaked at $65.7M in Q1 2019. 188 funds tracked by Wall St. Rank hold RGNX as of Q1 2024.

  • Perceptive Advisors reported no remaining Regenxbio position as of Q1 2024 after selling out during the quarter.
  • Perceptive Advisors sold 342,408 Regenxbio shares in Q1 2024, an estimated $6.15M.
  • Perceptive Advisors first reported a position in Regenxbio in Q3 2015 and held it in 23 quarters.
  • Perceptive Advisors's Regenxbio position peaked at $65.7M in Q1 2019.
  • 188 funds tracked by Wall St. Rank held Regenxbio as of Q1 2024.

Based on Perceptive Advisors's 13F filing for Q1 2024, filed 15 May 2024.